ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,963.84
      -1.22%
      US Tech 100
      20,829.20
      -1.67%
      Dow Jones
      42,949.06
      -0.87%
      Brent Oil
      73.815
      1.27%
      Bitcoin
      94,519.78
      -1.22%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Pharvaris NV (PHVS) Quote

      Pharvaris NV

      Pharvaris NV (PHVS)

      NASDAQ
      18.83
      -0.67
      ( -3.44% )
      Updated: 13:40:27
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      18.83
      Bid
      18.61
      Ask
      18.83
      Volume
      3,459
      18.83 Day's Range 19.50
      15.37 52 Week Range 33.00
      Market Cap
      984.625M
      Previous Close
      19.50
      Open
      19.44
      Last Trade
      9
      @
      18.61
      Last Trade Time
      13:37:55
      Financial Volume
      $ 65,884
      VWAP
      19.0472
      Average Volume (3m)
      85,896
      Shares Outstanding
      52,290,212
      Dividend Yield
      -
      PE Ratio
      -9.76
      Earnings Per Share (EPS)
      -1.93
      Revenue
      -
      Net Profit
      -100.88M

      About Pharvaris NV

      Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.pharvaris.com
      Headquarters
      Leiden, South Holland, Nld
      Founded
      -
      Pharvaris NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHVS. The last closing price for Pharvaris NV was $19.50. Over the last year, Pharvaris NV shares have traded in a share price range of $ 15.37 to $ 33.00.

      Pharvaris NV currently has 52,290,212 shares outstanding. The market capitalization of Pharvaris NV is $1.02 billion. Pharvaris NV has a price to earnings ratio (PE ratio) of -9.76.

      Ask ADVFN Intelligence (AI)

      PHVS Latest News

      More News

      Form 144 - Report of proposed sale of securities

      December 02 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 13 2024
      Edgar (US Regulatory)

      Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates

      Positive long-term extension data highlighting the differentiated profile of deucrictibant for the prevention and treatment of HAE attacks presented at recent medical congressesIntend to engage in...

      November 13 2024
      GlobeNewswire Inc.

      Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference

      ZUG, Switzerland, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

      November 12 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      October 31 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      October 24 2024
      Edgar (US Regulatory)

      Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting

      ZUG, Switzerland, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

      October 24 2024
      GlobeNewswire Inc.

      Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings

      ZUG, Switzerland, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

      October 16 2024
      GlobeNewswire Inc.

      Pharvaris to Host Virtual Investor Event on October 23, 2024

      ZUG, Switzerland, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

      October 15 2024
      GlobeNewswire Inc.

      Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop

      ZUG, Switzerland, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

      October 03 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.37-1.9270833333319.220.4818.324781919.41610686CS
      4-3.4-15.294646873622.2322.5517.828808419.30957972CS
      121.055.9055118110217.7825.498517.2758589621.10602765CS
      260.351.8939393939418.4825.498515.58510619.83851533CS
      52-7.42-28.266666666726.253315.378829522.36152209CS
      1563.1820.319488817915.65331.7722980012.63035391CS
      260-6.17-24.682542.861.7718818213.40878439CS

      PHVS - Frequently Asked Questions (FAQ)

      What is the current Pharvaris NV share price?
      The current share price of Pharvaris NV is $ 18.83
      How many Pharvaris NV shares are in issue?
      Pharvaris NV has 52,290,212 shares in issue
      What is the market cap of Pharvaris NV?
      The market capitalisation of Pharvaris NV is USD 1.02B
      What is the 1 year trading range for Pharvaris NV share price?
      Pharvaris NV has traded in the range of $ 15.37 to $ 33.00 during the past year
      What is the PE ratio of Pharvaris NV?
      The price to earnings ratio of Pharvaris NV is -9.76
      What is the reporting currency for Pharvaris NV?
      Pharvaris NV reports financial results in EUR
      What is the latest annual profit for Pharvaris NV?
      The latest annual profit of Pharvaris NV is EUR -100.88M
      What is the registered address of Pharvaris NV?
      The registered address for Pharvaris NV is EMMY NOETHERWEG 2, LEIDEN, SOUTH HOLLAND, 2333 BK
      What is the Pharvaris NV website address?
      The website address for Pharvaris NV is www.pharvaris.com
      Which industry sector does Pharvaris NV operate in?
      Pharvaris NV operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      INTZIntrusion Inc
      $ 1.895
      (321.11%)
      		148.81M
      HUBCWHub Cyber Security Ltd
      $ 0.0354
      (254.00%)
      		2.1M
      GTIGraphjet Technology
      $ 1.1085
      (227.47%)
      		346.42M
      AILEiLearningEngines Inc
      $ 0.5251
      (225.14%)
      		500.11M
      LITMSnow Lake Resources Ltd
      $ 1.685
      (91.48%)
      		110.93M
      NEUPNeuphoria Therapeutics Inc
      $ 4.0699
      (-92.38%)
      		880.72k
      VIRXViracta Therapeutics Inc
      $ 0.15
      (-36.71%)
      		6.67M
      PRFXPainReform Ltd
      $ 3.3319
      (-32.00%)
      		844.02k
      AIREreAlpha Tech Corporation
      $ 2.59
      (-27.65%)
      		7.29M
      TOIIWOncology Institute Inc
      $ 0.0072
      (-23.40%)
      		46.66k
      AILEiLearningEngines Inc
      $ 0.5251
      (225.14%)
      		500.11M
      GTIGraphjet Technology
      $ 1.1085
      (227.47%)
      		346.42M
      RGTIRigetti Computing Inc
      $ 17.66
      (14.38%)
      		244.19M
      XTIAXTI Aerospace Inc
      $ 0.04
      (0.00%)
      		232.79M
      QSIQuantum Si Inc
      $ 3.6246
      (68.59%)
      		203.49M

      PHVS Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      PHVS trying to break out of the recent channel
      👍️0
      Monksdream Monksdream 11 months ago
      PHVS new 52 week low
      👍️0
      europtiger europtiger 1 year ago
      Haven’t been here in a while… but this one is just a sweet long position. Soon to be 20+ imho
      👍️0
      subslover subslover 2 years ago
      Excellent call on the $12,00's. I just confirmed today's 12,24 is the 52-week high! :)
      👍️0
      europtiger europtiger 2 years ago
      Yeah looking great… my average now ist even 8,30 as I bought 2 more k when she was in the 7,s so I got lucky. Let’s see, hoping for 12 break soon here

      Good luck to you
      👍️0
      subslover subslover 2 years ago
      Your doing great closed $11.20 :)
      👍️0
      europtiger europtiger 2 years ago
      So I got now average 8,80$

      Let’s see I guess
      👍️0
      Pt3 Pt3 2 years ago
      What going on back to 7
      👍️0
      winna winna 2 years ago
      ???
      👍️0
      MT101 MT101 2 years ago
      Ez hold. Down 12% and you think it’s bearish after a 400% run hahahahah loaded more today too.
      👍️0
      winna winna 2 years ago
      You were saying?
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: "RED prices at morning, sailors take warning!!" (Well, something like that.)



      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS:: Were you referring to YOURSELF, Sir, with that post????? (See today's PHVS chart, below.)

      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: Where have all the smart-ass, know-it-all's gone??????? (Can't even discern conspicuous FLUFF PR's when ya see 'em!!!)

      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: The RED PRICE will edify you today --- so, ignore me if you like. Bottom line, Sir, you need a REMEDIAL course in how IGNORANT this primitive Planet is in the area of Human THERAPEUTIC Medical (so-called) "SCIENCE".
      👍️0
      MT101 MT101 2 years ago
      I actually just loaded every more in PM. This is going to explode at open most likely another 300-400% day. Your screwed dude you should have covered yesterday!
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      It is going NOWHERE, Dude. It had its run; it's DONE Hope you didn't hold any overnight.
      👍️0
      MT101 MT101 2 years ago
      Everything your saying is false. I sure hope your joking about being a short, your going to get toasted to a crisp today if you are.. this things about to go parabolic. Monday will probably blow up too. Easily $40+ here
      👍️0
      MT101 MT101 2 years ago
      Shorts are trapped this is HKD 2.0
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: It was a monster runner, that's for sure. GOOD LUCK today, however. (Pure FLUFF news, if there ever was any anywhere.)
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: I do NOT own any of this. And, if I ran Wall Street, SHORTING any stock would be prohibited by LAW. WHY?? Because such practice is betting on a Company to LOSE value. Bottom line, SHORTING stocks is yet another example of the CORRUPT nature of American Commerce, Industry, & Government at its CORE. Similar to how in America, just ONE GUY/GAL can win a ONE-BILLION-DOLLAR lottery all for their SELFISH SELVES!!!
      👍️0
      MT101 MT101 2 years ago
      Lol your going to lose your entire portfolio trying to short this one. Please be my guest! Love seeing shorts get their asses burned!
      👍️0
      MT101 MT101 2 years ago
      They will try but the buying pressure is way to aggressive right now and short shares are hard to find, I checked multiple platforms. Shorts that are holding there position overnight are going to get wrecked af tomorrow
      👍️0
      doebop doebop 2 years ago
      Agree best to wait for pop tomorrow then short if you can borrow
      👍️0
      Laster Laster 2 years ago
      Actually Hereditary Angioedema is very hard to treat. Different than ACE induced angioedema. News looks promising but it is phase 2 data. The bigger concern is that the FDA halted their US trials on August for some reason. Therefore, the company is only doing trials outside the US.

      Stock dropped $2 after hours. Let’s see how it trades Premarket.

      I almost got into this at $4.70 just around noon but the stock immediately exploded to $5.80. Never seen anything like that. I saw that it was a market buy order of about 150,000 shares. Wow.
      👍️0
      Pt3 Pt3 2 years ago
      Short can't short cuz this going to 20-30
      👍️0
      winna winna 2 years ago
      They will short this down tomorrow
      👍️0
      MT101 MT101 2 years ago
      Dude your so screwed if you don’t cover before tomorrow open. It’s going to $20-40
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      Watch out for RED INK tomorrow, behind this FLUFF-NEWS crap!!!
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: My post is the TRUTH, Dude; if you can't recognize pure FLUFF Medical "NEWS" --- & about an extremely RARE disease, to boot --- well then, nobody can help you, Sir. (GOOD LUCK!!!)
      👍️0
      MT101 MT101 2 years ago
      False. I recommend you cover your short or get burned out. This is going to $20-40 tomorrow. Tik Tok Tik Tok your running out of time.
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: Price SOARED today, & all behind the most FLUFF news of this calendar year so far!! (Maybe of this ENTIRE year, moving forward; a firm that is LOSING money every year, & barely past the "Proof Of Concept" stage for yet ANOTHER purported treatment for whatever.)
      👍️0
      MT101 MT101 2 years ago
      That’s good. I loaded 3k shares here around $10 range. I think this is going to $20-40 possibly. Massive news
      👍️0
      europtiger europtiger 2 years ago
      Got me 2,5 k shares just now below 10$

      Could see a nice buy out offer at some stage
      👍️0
      MT101 MT101 2 years ago
      Going to $20-30 range
      👍️0
      subslover subslover 2 years ago
      This stock has sure gone crazy! LMAO all the way to Wells Fargo!
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      PHVS: Indeed!!! NOT even that, per se --- really just "Proof of Concept"!! What a JOKE!! Hey, Dude, Wall Street is a GAMBLING CASINO. ANY stupid stock can SOAR; if some TRENDING/INFLUENTIAL folks or entities are pumping it, that is.

      This little PUMPED PUPPY might just Close today at circa 900% UP!!!
      👍️0
      subslover subslover 2 years ago
      HALTED for the 3rd time at 1;30 PM @ $11.93
      👍️0
      subslover subslover 2 years ago
      $10.00 just breached.
      👍️0
      winna winna 2 years ago
      They will short this big time
      👍️0
      Cosa Cosa 2 years ago
      This big move is from phase 2 results?
      👍️0
      subslover subslover 2 years ago
      Trading resumed at 12:30 pm @ $7.50. What a wild ride this turned out to be!
      👍️0
      davidsson10 davidsson10 2 years ago
      Yes, that'll work.....
      👍️0
      subslover subslover 2 years ago
      HALTED again 12;28pm @ $8.18
      👍️0
      subslover subslover 2 years ago
      Trading resumed at 12:17pm @ $7.00
      👍️0
      subslover subslover 2 years ago
      HALTED at noon @ $5.78
      👍️0
      subslover subslover 2 years ago
      Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update


      https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400295
      👍️0
      subslover subslover 2 years ago
      Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
      https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400291
      👍️0

      Your Recent History

      NASDAQ
      PHVS
      Pharvaris NV
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads